The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...

(美国商业资讯)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant ...

A retrospective analysis showed improved overall survival (OS) with Orca-T compared with post-transplant cyclophosphamide in ...

Mikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly ...

The following is a summary of “Steroid-resistant nephrotic syndrome due to renal-limited thrombotic microangiopathy and membranous nephropathy after allogeneic hematopoietic stem cell transplantation ...

28, 2025 — A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation ...

(Nasdaq: ALLO), a clinical-stage biotechnology company ... which leverages the clinically validated Dagger ® technology to drive CAR T cell expansion and prevent rejection, includes two distinct ...

Citation: Clinical trial shows fecal microbiota transplantation could help patients heal after stem cell transplantation (2025, January 28) retrieved 21 February 2025 from https://medicalxpress ...